Investor profile
Life Sciences Partners has backed 9 European tech companies across 13 funding rounds between 2006 and 2019, joining rounds totalling €291M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Merus | Netherlands | 3 | €126M |
| DNA Script | France | 1 | €34M |
| Atlantic Therapeutics | Ireland | 1 | €28M |
| Xeltis | Switzerland | 1 | €27M |
| Sequana Medical | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Merus | Series C | €73M | 2015-08 |
| DNA Script | Series B | €34M | 2019-04 |
| Merus | Series B | €31M | 2013-10 |
| Atlantic Therapeutics |
| 2 |
| €25M |
| Vivasure Medical | Ireland | 1 | €16M |
| Kuros Biosurgery | Switzerland | 1 | €14M |
| Nexstim | Finland | 1 | €11M |
| Mint Solutions | Netherlands | 2 | €9.4M |
| Series B |
| €28M |
| 2019-01 |
| Xeltis | Series B | €27M | 2014-12 |
| Merus | Series A | €22M | 2007-01 |
| Sequana Medical | Series C | €17M | 2014-04 |
| Vivasure Medical | Series C | €16M | 2016-09 |
| Kuros Biosurgery | Growth/Late | €14M | 2015-08 |
| Nexstim | Other | €11M | 2011-01 |
